New Study Says Proton Pump Inhibitors Increase Risk Of Early Death - O'Connor Acciani & Levy

New Study Says Proton Pump Inhibitors Increase Risk Of Early Death

July 12, 2017 | By O'Connor Acciani & Levy
New Study Says Proton Pump Inhibitors Increase Risk Of Early Death

Proton pump inhibitors, or PPIs, are a popular group of medications used to treat heartburn. Unfortunately, a recent study has linked prescription PPI use to a 25 percent increased risk of early death. The key takeaways from the study are explained below. If you or a loved one has been harmed by taking PPIs prescribed by a doctor, contact the Cincinnati defective drug lawyers of O’Connor, Acciani & Levy to determine if you have legal options.

Findings From The Study

The PPI study evaluated patient medical information from the U.S. Department of Veterans Affairs, examining records of PPI patients as well as patients taking H2 blockers, another class of medications commonly used to treat heartburn. They analyzed data on 275,933 people who were prescribed a PPI and 73,355 who were prescribed an H2 blocker. Researchers found that patients taking PPIs had a 25 percent increased risk of early death from any cause compared to patients taking H2 blockers. The early death risk increased the longer a patient was treated with PPIs. The same increased risk of early death was found in PPI users when compared to patients not consuming H2 blockers. Despite this risk, those taking PPIs should not stop taking them unless they are advised to do so by their doctor. Researchers noted that further research is needed to determine all of the risks of these medications and the severity of those risks. The study was conducted by researchers from the Washington University School of Medicine and published in the online journal British Medical Journal (BMJ) Open. One of the shortcomings of the study is that it only examined prescription PPI use. Some PPIs are available over-the-counter without a prescription. AstraZeneca, manufacturer of prescription and over-the-counter PPI brands Nexium and Prilosec, is confident in the safety and efficacy of its PPI medications when they are used according to instructions on U.S. Food and Drug Administration labeling, according to a spokeswoman.

Past Studies On Ppis

Previous studies have shown that patients treated with PPIs were at a greater risk of the following health problems:
  • Cardiovascular disease
  • Chronic kidney disease or acute kidney injury
  • Pneumonia
  • Dementia
  • Fractures
  • Stomach infections

Contact Our Cincinnati Defective Drug Lawyers For A Free Consulrarion

The experienced attorneys at O’Connor, Acciani & Levy fight for justice and compensation for those who have suffered adverse events due to dangerous medications like PPIs. If this has happened to you, contact us to find out if we can file a Prilosec lawsuit or a Nexium lawsuit to try to recover compensation for medical bills, lost wages, and pain and suffering. Your initial consultation is free and there is no obligation to pursue legal action. Should you decide to move forward with our firm, we will not charge legal fees unless you receive compensation.